However, up until recently, most stakeholders used their own internal tools and proprietary identifiers for tracing investigational products and their locations, as well as for data interchange in clinical trials.
As a result, participants had to configure their IT systems to adapt to each solution implemented by each specific Investigational Medicinal Product (IMP) manufacturer.
Are you interested in learning more about how GS1 standards and services can move your business forward?